AXSM logo

Axsome Therapeutics
AXSM

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
$7.47B
EV
$7.36B
Shares Outstanding
55.49M
Beta
0.47
Industry
Biotechnology

Wall Street View

Analyst Rating
BUY
Analyst Target Price
Number of Analysts
20
P/E 2025E
-
P/Revenue 2025E
11.85x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2025E
91.86%
Net Profit Margin 2025E
-29.84%
ROE 2025E
-399.88%
ROCE 2024
-231.63%

Dividends

DPS 2025E
$0.00
Payout Ratio 2025E
0.00%
Div. Yield 2025E
0.00%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Axsome Therapeutics, Inc.

gainify
AXSM logo

Axsome Therapeutics, Inc.

AXSM

Axsome Therapeutics, Inc., a biopharmaceutical company, develops and delivers novel therapies for the management of central nervous system (CNS) disorders in the United States. The company’s commercial product portfolio includes Auvelity (dextromethorphan-bupropion), ...

Sector

Healthcare

Industry

Biotechnology

CEO

Tabuteau, Herriot

Employees

816

IPO Date

2015-11-19

Headquarters

One World Trade Center, 22nd Floor, New York, New York, 10007, United States

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.